(Q37854845)

24 August 2017

1 reference

title

Surgical wound complications after heart transplantation (English)

1 reference

24 August 2017

0 references

Andreas Zuckermann

1

1 reference

24 August 2017

Markus J Barten

series ordinal

2

1 reference

24 August 2017

publication date

21 March 2011

1 reference

24 August 2017

published in

Transplant International

1 reference

24 August 2017

volume

24

1 reference

24 August 2017

issue

7

1 reference

24 August 2017

page(s)

627-636

1 reference

The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report--2010.

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Infections of the mediastinum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

21 January 2018

Sternal wound infections

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

De novo immunosuppression with sirolimus and tacrolimus in heart transplant recipients compared with cyclosporine and mycophenolate mofetil: a one-year follow-up analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Superficial and deep sternal wound infection after more than 9000 coronary artery bypass graft (CABG): incidence, risk factors and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Infections following major heart surgery in European intensive care units: there is room for improvement (ESGNI 007 Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Surgical site infection after cardiac surgery: a simplified surveillance method

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Prevention of sternal dehiscence and infection in high-risk patients: a prospective randomized multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Superficial wound dehiscence after median sternotomy: surgical treatment versus secondary wound healing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Sternal wound infection after heart transplantation: incidence and results with aggressive surgical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Mediastinitis in heart and lung transplantation: 15 years experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Bacterial mediastinitis after heart transplantation: clinical presentation, risk factors and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Incidence, treatment strategies and outcome of deep sternal wound infection after orthotopic heart transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Adverse effects of mammalian target of rapamycin inhibitors during the postoperative period after cardiac transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Incisional surgical infection in heart transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Surgical treatment of mediastinitis after cardiac transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

A risk index for sternal surgical wound infection after cardiovascular surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Deep sternal wound infection: risk factors and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Prevention and management of deep sternal wound infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

The impact of deep sternal wound infection on long-term survival after coronary artery bypass grafting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Risk factors for mediastinitis after cardiac surgery - a retrospective analysis of 1700 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Are wound complications after a kidney transplant more common with modern immunosuppression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Risk factors for impaired wound healing in sirolimus-treated renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)-dependent signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Defects in skin gamma delta T cell function contribute to delayed wound repair in rapamycin-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Persistent effects of everolimus on strength of experimental wounds in intestine and fascia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Active drug transport of immunosuppressants: new insights for pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Sirolimus, but not the structurally related RAD (everolimus), enhances the negative effects of cyclosporine on mitochondrial metabolism in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Biomarkers for toxicodynamic monitoring of immunosuppressants: NMR-based quantitative metabonomics of the blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Everolimus plus reduced-exposure CsA versus mycophenolic acid plus standard-exposure CsA in renal-transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Everolimus with reduced cyclosporine versus MMF with standard cyclosporine in de novo heart transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

First experience with de novo calcineurin-inhibitor-free immunosuppression following cardiac transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Tolerance profile of the proliferation signal inhibitors everolimus and sirolimus in heart transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Vacuum-assisted closure for sternal wounds: a first-line therapeutic management approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Multidisciplinary insights on clinical guidance for the use of proliferation signal inhibitors in heart transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Clinical recommendations for the use of everolimus in heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

Incidence of delayed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01247.X

10.1111/J.1432-2277.2011.01247.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference